Cardiovascular monitoring device market seen reaching $5.13 billion by 2030

The global market for cardiovascular monitoring and diagnostic devices is projected to grow from $4.34 billion in 2026 to $5.13 billion by 2030, driven by rising heart disease risk, wider use of remote monitoring and adoption of AI-assisted diagnostics. North America led the market in 2025, while home-based and wireless tools are expected to gain share.

Why it matters: - Cardiovascular monitoring and diagnostic devices sit at the center of heart disease detection and treatment. - Rising obesity and diabetes rates are increasing demand for tools that can track cardiac health earlier and more often. - The market outlook signals more spending on remote care, digital diagnostics and non-invasive monitoring.

What happened: - The market was valued at $4.12 billion in 2025 and is projected to reach $4.34 billion in 2026. - The market is forecast to climb to $5.13 billion by 2030. - The projected 2026-2030 compound annual growth rate is 4.3%. - North America held the largest share of the global market in 2025. - Western Europe ranked as the second-largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Growth through 2026 reflects higher cardiovascular disease prevalence, broader availability of hospital-based diagnostic tools, greater use of ECG monitoring systems and more awareness of preventive cardiac care. - Future growth is linked to demand for home-based cardiac monitoring systems, AI-assisted diagnostic technologies, telecardiology services and digital healthcare infrastructure. - Expected product trends include remote cardiac monitoring, wearable ECG devices, cloud-based data management, continuous monitoring and wireless monitoring. - The report says cardiovascular monitoring and diagnostic devices help detect, track and manage cardiovascular conditions. - The report links obesity and diabetes to higher cardiovascular disease risk through factors including high blood pressure and elevated cholesterol. - A study cited in the release projects 22.2 million cardiovascular disease cases by 2030. - A second cited report says 26 million people in the United States have been diagnosed with diabetes, and more than 9 million remain undiagnosed. - The release offers a free sample of the market report and a full report. - The 2026 market reports add market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and key technologies and future trend analysis.

Between the lines: - The forecast points to a shift from hospital-centered diagnostics toward home and wireless monitoring. - AI and cloud integration suggest the market is moving toward more continuous, data-heavy care models. - The obesity and diabetes backdrop implies demand is being pushed by chronic disease burden, not just by device innovation.

What's next: - The strongest growth areas are likely to be home-based monitoring, wearable ECG tools and telecardiology. - Ongoing investment in digital health infrastructure should support broader adoption of connected diagnostic devices. - Early-detection tools may become more important as providers look to manage cardiovascular risk before symptoms worsen.

The bottom line: - Cardiovascular monitoring and diagnostic devices are set for steady growth as chronic disease rates rise and care moves closer to the patient.